Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone

被引:71
作者
Pericas, J. M. [1 ]
Cervera, C. [1 ]
del Rio, A. [1 ]
Moreno, A. [1 ]
Garcia de la Maria, C. [1 ]
Almela, M. [2 ]
Falces, C. [3 ]
Ninot, S. [4 ]
Castaneda, X. [1 ]
Armero, Y. [1 ]
Soy, D. [5 ]
Gatell, J. M. [1 ]
Marco, F. [2 ]
Mestres, C. A. [4 ]
Miro, J. M. [1 ]
机构
[1] Univ Barcelona, Infect Dis Serv, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
[2] Univ Barcelona, Microbiol Serv, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
[3] Univ Barcelona, Serv Cardiol, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
[4] Univ Barcelona, Dept Cardiovasc Surg, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
[5] Univ Barcelona, Serv Pharm, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain
关键词
Ampicillin plus ceftriaxone; antimicrobial treatment; Enterococcus faecalis; high-level aminoglycoside resistance; infective endocarditis; outcomes; HIGH-LEVEL RESISTANCE; INTERNATIONAL-COLLABORATION; MOLECULAR EPIDEMIOLOGY; DIAGNOSIS; EFFICACY; THERAPY; GUIDELINES; MANAGEMENT; STATEMENT; STRAINS;
D O I
10.1111/1469-0691.12756
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to assess changes in antibiotic resistance, epidemiology and outcome among patients with Enterococcus faecalis infective endocarditis (EFIE) and to compare the efficacy and safety of the combination of ampicillin and gentamicin (A+G) with that of ampicillin plus ceftriaxone (A+C). The study was a retrospective analysis of a prospective cohort of EFIE patients treated in our centre from 1997 to 2011. Thirty patients were initially treated with A+G (ampicillin 2g/4h and gentamicin 3mg/kg/day) and 39 with A+C (ampicillin 2g/4h and ceftriaxone 2g/12h) for 4-6weeks. Increased rates of high-level aminoglycoside resistance (HLAR; gentamicin MIC 512mg/L, streptomycin MIC 1024mg/L or both) were observed in recent years (24% in 1997-2006 and 49% in 2007-2011; p0.03). The use of A+C increased over time: 1997-2001, 4/18 (22%); 2002-2006, 5/16 (31%); 2007-2011, 30/35 (86%) (p<0.001). Renal failure developed in 65% of the A+G group and in 34% of the A+C group (p0.014). Thirteen patients (43%) in the A+G group had to discontinue treatment, whereas only one patient (3%) treated with A+C had to discontinue treatment (p<0.001). Only development of heart failure and previous chronic renal failure were independently associated with 1-year mortality, while the individual antibiotic regimen (A+C vs. A+G) did not affect outcome (OR, 0.7; 95% CI, 0.2-2.2; p0.549). Our study shows that the prevalence of HLAR EFIE has increased significantly in recent years and that alternative treatment with A+C is safer than A+G, with similar clinical outcomes, although the sample size is too small to draw firm conclusions. Randomized controlled studies are needed to confirm these results.
引用
收藏
页码:O1075 / O1083
页数:9
相关论文
共 36 条
  • [1] Enterococcal prosthetic valve infective endocarditis: report of 45 episodes from the International Collaboration on Endocarditis-merged database
    Anderson, DJ
    Olaison, L
    McDonald, JR
    Miro, JM
    Hoen, B
    Selton-Suty, C
    Doco-Lecompte, T
    Abrutyn, E
    Habib, G
    Eykyn, S
    Pappas, PA
    Fowler, VG
    Sexton, DJ
    Almela, M
    Corey, GR
    Cabell, CH
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (10) : 665 - 670
  • [2] CLINICAL AND MOLECULAR EPIDEMIOLOGY OF ENTEROCOCCUS-FAECALIS BACTEREMIA, WITH SPECIAL REFERENCE TO STRAINS WITH HIGH-LEVEL RESISTANCE TO GENTAMICIN
    ANTALEK, MD
    MYLOTTE, JM
    LESSE, AJ
    SELLICK, JA
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (01) : 103 - 109
  • [3] A surveillance of high-level gentamicin-resistant enterococcal bacteremia
    Araoka, Hideki
    Kimura, Muneyoshi
    Yoneyama, Akiko
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (03) : 433 - 434
  • [4] TRENDS IN GLYCOPEPTIDE AND DAPTOMYCIN SUSCEPTIBILITIES IN STAPHYLOCOCCUS EPIDERMIDIS ISOLATED FROM INFECTIVE ENDOCARDITIS (IE) OVER TIME (1992-2008)
    Armero, Y.
    Garcia de la Maria, C.
    Cervera, C.
    Moreno, A.
    Ninot, S.
    Almela, M.
    del Rio, A.
    Falces, C.
    Mestres, C.
    Jimenez de Anta, M.
    Gatell, J.
    Marco, F.
    Miro, J.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 : S33 - S33
  • [5] Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564
  • [6] Health Care-Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
    Benito, Natividad
    Miro, Jose M.
    de Lazzari, Elisa
    Cabell, Christopher H.
    del Rio, Ana
    Altclas, Javier
    Commerford, Patrick
    Delahaye, Francois
    Dragulescu, Stefan
    Giamarellou, Helen
    Habib, Gilbert
    Kamarulzaman, Adeeba
    Kumar, A. Sampath
    Nacinovich, Francisco M.
    Suter, Fredy
    Tribouilloy, Christophe
    Venugopal, Krishnan
    Moreno, Asuncion
    Fowler, Vance G., Jr.
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (09) : 586 - U5
  • [7] Changing patient characteristics and the effect on mortality in endocarditis
    Cabell, CH
    Jollis, JG
    Peterson, GE
    Corey, GR
    Anderson, DJ
    Sexton, DJ
    Woods, CW
    Reller, LB
    Ryan, T
    Fowler, VG
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (01) : 90 - 94
  • [8] Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study
    Chirouze, C.
    Athan, E.
    Alla, F.
    Chu, V. H.
    Corey, G. Ralph
    Selton-Suty, C.
    Erpelding, M-L
    Miro, J. M.
    Olaison, L.
    Hoen, B.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (12) : 1140 - 1147
  • [9] Enterococcus faecalis Infective Endocarditis A Pilot Study of the Relationship Between Duration of Gentamicin Treatment and Outcome
    Dahl, Anders
    Rasmussen, Rasmus V.
    Bundgaard, Henning
    Hassager, Christian
    Bruun, Louise E.
    Lauridsen, Trine K.
    Moser, Claus
    Sogaard, Peter
    Arpi, Magnus
    Bruun, Niels E.
    [J]. CIRCULATION, 2013, 127 (17) : 1810 - 1817
  • [10] DONOWITZ GR, 1988, NEW ENGL J MED, V318, P490